HealthBiz with David E. Williams
The HealthBiz podcast features in-depth interviews on healthcare business, technology and policy with entrepreneurs and CEOs. Host David E. Williams is president of healthcare strategy consulting boutique, Health Business Group https://healthbusinessgroup.com/ a board member and investor in private healthcare companies, and author of the Health Business Blog. His strategic and humorous approach to healthcare provides a refreshing break from the usual BS. Connect with David on LinkedIn https://www.linkedin.com/in/davideugenewilliams
HealthBiz with David E. Williams
Remdesivir powers, activate! Surya Singh
Wouldn’t it be great if remdesivir magically cured COVID-19? Too bad it doesn’t. So what should we be willing to pay for a drug that shortens hospital stays and might reduce mortality? In this episode of HealthBiz, physician and healthcare executive Surya Singh shares his take on drug pricing, ICER and the future of the pandemic.
Check out the links.
- Surya’s LinkedIn profile https://www.linkedin.com/in/surya-singh-8540032/
- Institute for Clinical and Economic Review (ICER) remdesivir pricing model https://icer-review.org/announcements/alternative_pricing_models_for_remdesivir/
- Letter from State Attorneys General about remdesivir pricing https://patreasury.gov/pdf/newsroom/Gilead-Sciences-Letter_Redacted.pdf
- Boston Globe article comparing MA and RI school reopening plans https://www.bostonglobe.com/2020/09/18/metro/how-rhode-island-brought-most-students-back-in-person-learning-massachusetts-did-not/
- Remdesivir https://www.gilead.com/remdesivir
- Inspiration for “Remdesivir powers, activate!” https://youtu.be/FouDjI3GzEI
- David’s LinkedIn profile https://www.linkedin.com/in/davideugenewilliams/
- Health Business Group https://healthbusinessgroup.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.